Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
25.02.26
/
50%
€3.57
Target price
25.02.27
€9.33
Performance (%)
5.47%
Price
04.06.26
€3.77
Summary
This prediction is currently active. With a performance of 5.47%, the BUY prediction by Barclays_PLC for Iovance Biotherapeutics Inc. is trending in the right direction. This prediction currently runs until 25.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -12.783% | -12.783% |
| iShares Core DAX® | -1,76 % | 1,67 % |
| iShares Nasdaq 100 | 2,32 % | 12,78 % |
| iShares Nikkei 225® | 5,02 % | 13,30 % |
| iShares S&P 500 | 0,80 % | 6,20 % |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics (IOVA) had its price target raised by Barclays PLC from $10.00 to $11.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Barclays_PLC for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.44
24.12.25
24.12.25
€8.47
24.12.26
24.12.26
54.41%
04.06.26
04.06.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
12.05.25
12.05.25
€3.56
12.05.26
12.05.26
85.46%
13.05.26
13.05.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.00
14.04.25
14.04.25
€4.39
14.04.26
14.04.26
0.70%
15.04.26
15.04.26
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€15.05
29.02.24
29.02.24
€20.28
28.02.25
28.02.25
-73.24%
01.03.25
01.03.25